文献

J-GLOBAL ID：201802243592113532   整理番号：18A0118555

有効性改善のための自己集合カンプトテシンとカペシタビンハイブリッドプロドラッグの相乗的抗腫瘍活性

Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy

著者 (14件)： Ma Wang (Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Eastern Road, Zhengzhou 450052, Henan, China) ,  Su Hao (Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Su Hao (Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Cheetham Andrew G. (Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Cheetham Andrew G. (Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Zhang Weifang (Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Eastern Road, Zhengzhou 450052, Henan, China) ,  Wang Yuzhu (Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Wang Yuzhu (Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Kan QuanCheng (Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Eastern Road, Zhengzhou 450052, Henan, China) ,  Cui Honggang (Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Eastern Road, Zhengzhou 450052, Henan, China) ,  Cui Honggang (Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Cui Honggang (Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD 21218, USA) ,  Cui Honggang (Department of Oncology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA) ,  Cui Honggang (Center for Nanomedicine, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, 400 North Broadway, Baltimore, MD 21231, USA)
資料名： Journal of Controlled Release  (Journal of Controlled Release)
巻： 263  ページ： 102-111  発行年： 2017年10月10日 
JST資料番号： C0308D  ISSN： 0168-3659  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： 抗癌薬自身のナノ構造を創作するための抗癌薬の直接使用は,高い...

シソーラス用語： *ドラッグデリバリーシステム ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0118555&from=J-GLOBAL&jstjournalNo=C0308D") }}

著者キーワード (5件)： 薬物複合体 ,  カペシタビン ,  カンプトテシン ,  ドラッグデリバリー ,  化学療法

分類 (2件)： 生物薬剤学(基礎)  (GY01021U) ,  腫ようの実験的治療  (GE02040Y)

物質索引 (2件)： カンプトテシン ,  カペシタビン

引用文献 (74件)：

• D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R Langer, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol. 2 (2007) 751-760.
• R.A. Petros, J.M. DeSimone, Strategies in the design of nanoparticles for therapeutic applications, Nat. Rev. Drug Discov. 9 (2010) 615-627.
• L Brannon-Peppas, J.O. Blanchette, Nanoparticle and targeted systems for cancer therapy, Adv. Drug Deliv. Rev. 64 (2012) 206-212.
• I. Brigger, C. Dubernet, P. Couvreur, Nanoparticles in cancer therapy and diagnosis, Adv. Drug Deliv. Rev. 64 (2012) 24-36.
• E. Miele, G.P. Spinelli, E. Miele, F. Tomao, S. Tomao, Albumin-bound formulation of paclitaxel (Abraxane (R) ABI-007) in the treatment of breast cancer, Int. J. Nanomedicine 4 (2009) 99-105.

タイトルに関連する用語 (4件)： 有効性 ,  自己集合 ,  カンプトテシン ,  抗腫瘍活性